Suchergebnisse - "Exemestane"

PubPharm (254)

1

Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept

enthalten in: Analytical and bioanalytical chemistry | 2024

von Jacobs, C. | Radosa, J. | Wagmann, L. | +8

2

Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China

enthalten in: Clinical breast cancer | 2024

von Zhong, X. | Chen, P. | He, P. | +7

3

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer : Long-Term Follow-Up of the Combined TEXT and SOFT Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Pagani, O. | Walley, B. | Fleming, G. | +24

CommentIn: J Clin Oncol. 2023 Mar 1;41(7):1339-1341. - PMID 36521079

4

Characterization of Cytosolic Glutathione S-Transferases Involved in the Metabolism of the Aromatase Inhibitor, Exemestane

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2021

von Teslenko, I. | Watson, C. | Xia, Z. | +2

5

Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer

enthalten in: Clinical pharmacology and therapeutics | 2021

von Cairns, J. | Kalari, K. | Ingle, J. | +10

6

Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer : Patient-reported outcomes in the PEARL study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Kahan, Z. | Gil-Gil, M. | Ruiz-Borrego, M. | +26

7

Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer : Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)

enthalten in: Cancer research and treatment | 2021

von Lee, J. | Im, S. | Kim, G. | +6

8

Influence of the competing risk of death on estimates of disease recurrence in trials of adjuvant endocrine therapy for early-stage breast cancer : A secondary analysis of MA.27, MA.17 and MA.17R

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Ethier, J. | Anderson, G. | Austin, P. | +6

9

Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer : a systematic review

enthalten in: Breast cancer (Tokyo, Japan) | 2021

von Shirdarreh, M. | Pezo, R.

10

Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer : Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Noordhoek, I. | Blok, E. | Meershoek-Klein Kranenbarg, E. | +15

CommentIn: J Clin Oncol. 2021 Feb 1;39(4):338-339. - PMID 33326252

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]